AbbVie raises profit outlook on Botox recovery signs, new drugs growth

And that gets you pretty close to covering all of Humira in the United States,” he said. Third-quarter sales for Botox’s cosmetic use fell 2.2% year-on-year to $393 million, recovering from a 43.1% …
( read original story …)


Advertisement